Caprelsa, is a kinase inhibitor used to treat patients with medullary thyroid cancer (MTC) and non-small cell lung cancer
With a soft/caring tone, the name Caprelsa is derived from ‘capacity’, ‘reliable’ and ‘relief’, suggesting support, efficacy and peace of mind/less-worry.
